A new UPMC report found that while most health systems now offer precision medicine programs, many still face challenges scaling them due to reimbursement, data integration and patient engagement issues. Health system leaders say the field’s future depends on embedding genomics into routine care, as well as proving its clinical and financial value.
The post Precision Medicine’s Next Hurdle Isn’t Science — It’s Execution appeared first on MedCity News.
